Marvell (MRVL) Stock Plunges 7% Following Analyst Downgrade

Wait 5 sec.

Key TakeawaysErste Group Bank lowered Marvell Technology (MRVL) from Buy to Hold, pointing to elevated valuation and concentration in its customer baseShares declined 7.3%, reaching an intraday low of $201.22 following a previous close at $222.44Wall Street’s overall outlook stays at “Moderate Buy” with a mean price target of $245.45The company delivered 27.6% revenue growth year-over-year in its latest quarter, projecting 35% growth and approximately $0.93 EPS for Q2Broader semiconductor sector headwinds, including Micron’s 8% decline on Chinese competition concerns, compounded selling pressureMarvell Technology (MRVL) experienced a sharp 7.3% decline Wednesday following Erste Group Bank’s decision to downgrade the stock from Buy to Hold. Trading volume surged to approximately 26.6 million shares as the stock touched $201.22, sliding from its prior session close of $222.44.Marvell Technology, Inc., MRVLErste Group’s analyst Hans Engel highlighted two primary issues behind the rating change: stretched valuation metrics and significant reliance on a concentrated customer roster. With a price-to-earnings multiple of 73.56, Engel noted the stock trades at a premium relative to industry peers. Analysis from InvestingPro’s Fair Value framework also categorizes MRVL as trading above its intrinsic value.However, the company’s PEG ratio of 0.13 presents a contrasting perspective—indicating the current valuation could be justified if management delivers on aggressive growth projections.Analyst Community Maintains Optimistic StanceErste Group’s cautious view represents a minority opinion among Wall Street analysts. According to MarketBeat data covering 37 analysts, three assign Strong Buy ratings, 27 recommend Buy, and seven maintain Hold positions. The average target price stands at $245.45—substantially higher than current trading levels.B. Riley recently boosted its price objective to $345, highlighting Marvell’s strategic collaboration with Nvidia. UBS increased its forecast to $340, emphasizing expansion opportunities in CXL technology platforms. JPMorgan elevated its target to $240 while maintaining an Overweight stance.Oppenheimer maintains an Outperform rating with a $250 target. Cantor Fitzgerald, despite holding a Neutral position, raised its price objective to $300.Strong Operational Performance ContinuesIn its most recent quarterly report, Marvell posted revenue of $2.42 billion—a 27.6% year-over-year increase—alongside EPS of $0.80, precisely meeting Wall Street estimates. The company achieved a net margin of 28.99% with return on equity reaching 13.83%.Looking ahead to Q2 fiscal 2027, management forecasts approximately $2.7 billion in revenue, representing 35% annual growth. Earnings per share are expected to land near $0.93, with gross margin guidance ranging between 52.1% and 53.1%.Wednesday’s sell-off wasn’t solely attributable to the downgrade. Broader semiconductor sector turbulence contributed significantly, as Micron plummeted 8% on fears of intensifying Chinese competition, creating ripple effects across Intel, AMD, and Marvell.Insider activity showed CFO Dan Durn divested 2,250 shares at $281.01 on June 23rd—trimming his holdings by 24.58%. Former CFO Willem Meintjes previously sold 4,000 shares at $175.24 in May. Collectively, insiders disposed of 122,873 shares valued at roughly $19.9 million during the past quarter.Institutional investors maintain substantial ownership at 83.51%. The stock’s 50-day moving average registers at $238.91, while the 200-day average sits at $147.23—illustrating the significant appreciation over the trailing twelve months.Marvell announced a quarterly dividend of $0.06 per share, scheduled for payment on July 30 to shareholders on record as of July 10.The post Marvell (MRVL) Stock Plunges 7% Following Analyst Downgrade appeared first on Blockonomi.